Somatic cell-derived organoids as prototypes of human epithelial tissues and diseases
Source abstract
Abstract
Recent progress in our understanding of the regulation of epithelial tissue stem cells has allowed us to exploit their abilities and instruct them to self-organize into tissue-mimicking structures, so-called organoids. Organoids preserve the molecular, structural and functional characteristics of their tissues of origin, thus providing an attractive opportunity to study the biology of human tissues in health and disease. In parallel to deriving organoids from yet-uncultured epithelial tissues, the field is devoting a growing amount of effort to model human diseases using organoids. This Review describes multidisciplinary approaches for creating organoid models of human genetic, neoplastic, immunological and infectious diseases, and details how they have contributed to our understanding of disease biology. We further highlight the potential role as well as limitations of organoids in clinical practice and showcase the latest achievements and approaches for tuning the organoid culture system to position organoids in biologically defined settings and to grant organoids with better representation of human tissues.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Cancer Cells and Metastasis · Renal and related cancers · 3D Printing in Biomedical Research
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (100+)
Show source-provided references
1. Lancaster, M. A. & Knoblich, J. A. Organogenesis in a dish: modeling development and disease using organoid technologies. Science 345, 1247125 (2014).10.1126/science.1247125 ↗
2. Shamir, E. R. & Ewald, A. J. Three-dimensional organotypic culture: experimental models of mammalian biology and disease. Nat. Rev. Mol. Cell Biol. 15, 647–664 (2014).10.1038/nrm3873 ↗
3. Stelzner, M. et al. A nomenclature for intestinal in vitro cultures. Am. J. Physiol. Gastrointest. Liver Physiol. 302, G1359–G1363 (2012).10.1152/ajpgi.00493.2011 ↗
4. Date, S. & Sato, T. Mini-gut organoids: reconstitution of the stem cell niche. Annu. Rev. Cell Dev. Biol. 31, 269–289 (2015).10.1146/annurev-cellbio-100814-125218 ↗
5. Sato, T. et al. Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche. Nature 459, 262–265 (2009).10.1038/nature07935 ↗
6. Karthaus, W. R. et al. Identification of multipotent luminal progenitor cells in human prostate organoid cultures. Cell 159, 163–175 (2014).10.1016/j.cell.2014.08.017 ↗
7. Jarde, T. et al. Wnt and Neuregulin1/ErbB signalling extends 3D culture of hormone responsive mammary organoids. Nat. Commun. 7, 13207 (2016).10.1038/ncomms13207 ↗
8. Criscimanna, A. et al. Duct cells contribute to regeneration of endocrine and acinar cells following pancreatic damage in adult mice. Gastroenterology 141, 1451–1462 (2011).10.1053/j.gastro.2011.07.003 ↗
9. Huch, M. et al. Unlimited in vitro expansion of adult bi-potent pancreas progenitors through the Lgr5/R-spondin axis. EMBO J. 32, 2708–2721 (2013).10.1038/emboj.2013.204 ↗
10. Boulter, L. et al. Macrophage-derived Wnt opposes Notch signaling to specify hepatic progenitor cell fate in chronic liver disease. Nat. Med. 18, 572–579 (2012).10.1038/nm.2667 ↗
11. Huch, M. et al. In vitro expansion of single Lgr5+ liver stem cells induced by Wnt-driven regeneration. Nature 494, 247–250 (2013).10.1038/nature11826 ↗
12. Planas-Paz, L. et al. The RSPO-LGR4/5-ZNRF3/RNF43 module controls liver zonation and size. Nat. Cell Biol. 18, 467–479 (2016).10.1038/ncb3337 ↗
13. Lin, S. et al. Distributed hepatocytes expressing telomerase repopulate the liver in homeostasis and injury. Nature 556, 244–248 (2018).10.1038/s41586-018-0004-7 ↗
14. Clevers, H. Modeling development and disease with organoids. Cell 165, 1586–1597 (2016).10.1016/j.cell.2016.05.082 ↗
15. Driehuis, E. et al. Oral mucosal organoids as a potential platform for personalized cancer therapy. Cancer Discov. 9, 852–871 (2019).10.1158/2159-8290.CD-18-1522 ↗
16. Sachs, N. et al. Long-term expanding human airway organoids for disease modeling. EMBO J. 38, e100300 (2019).10.15252/embj.2018100300 ↗
17. Kim, M. et al. Patient-derived lung cancer organoids as in vitro cancer models for therapeutic screening. Nat. Commun. 10, 3991 (2019).
18. Sachs, N. et al. A living biobank of breast cancer organoids captures disease heterogeneity. Cell 172, 373–386 (2018).10.1016/j.cell.2017.11.010 ↗
19. Dekkers, J. F. et al. Modeling breast cancer using CRISPR/Cas9-mediated engineering of human breast organoids. J. Natl Cancer Inst. 112, 540–544 (2019).10.1093/jnci/djz196 ↗
20. Jiang, M. et al. Transitional basal cells at the squamous-columnar junction generate Barrett’s oesophagus. Nature 550, 529–533 (2017).10.1038/nature24269 ↗
21. Kasagi, Y. et al. The esophageal organoid system reveals functional interplay between Notch and cytokines in reactive epithelial changes. Cell. Mol. Gastroenterol. Hepatol. 5, 333–352 (2018).10.1016/j.jcmgh.2017.12.013 ↗
22. Bartfeld, S. et al. In vitro expansion of human gastric epithelial stem cells and their responses to bacterial infection. Gastroenterology 148, 126–136 (2015).10.1053/j.gastro.2014.09.042 ↗
23. Sato, T. et al. Long-term expansion of epithelial organoids from human colon, adenoma, adenocarcinoma, and Barrett’s epithelium. Gastroenterology 141, 1762–1772 (2011).10.1053/j.gastro.2011.07.050 ↗
24. Fujii, M. et al. Human intestinal organoids maintain self-renewal capacity and cellular diversity in niche-inspired culture condition. Cell Stem Cell 23, 787–793 (2018).10.1016/j.stem.2018.11.016 ↗
25. Huch, M. et al. Long-term culture of genome-stable bipotent stem cells from adult human liver. Cell 160, 299–312 (2015).10.1016/j.cell.2014.11.050 ↗
26. Hu, H. et al. Long-term expansion of functional mouse and human hepatocytes as 3D organoids. Cell 175, 1591–1606 (2018).10.1016/j.cell.2018.11.013 ↗
27. Sampaziotis, F. et al. Reconstruction of the mouse extrahepatic biliary tree using primary human extrahepatic cholangiocyte organoids. Nat. Med. 23, 954–963 (2017).10.1038/nm.4360 ↗
28. Lugli, N. et al. R-spondin 1 and noggin facilitate expansion of resident stem cells from non-damaged gallbladders. EMBO Rep. 17, 769–779 (2016).10.15252/embr.201642169 ↗
29. Boj, S. F. et al. Organoid models of human and mouse ductal pancreatic cancer. Cell 160, 324–338 (2015).10.1016/j.cell.2014.12.021 ↗
30. Seino, T. et al. Human pancreatic tumor organoids reveal loss of stem cell niche factor dependence during disease progression. Cell Stem Cell 22, 454–467 (2018).10.1016/j.stem.2017.12.009 ↗
31. Schutgens, F. et al. Tubuloids derived from human adult kidney and urine for personalized disease modeling. Nat. Biotechnol. 37, 303–313 (2019).10.1038/s41587-019-0048-8 ↗
32. Mullenders, J. et al. Mouse and human urothelial cancer organoids: a tool for bladder cancer research. Proc. Natl Acad. Sci. USA 116, 4567–4574 (2019).10.1073/pnas.1803595116 ↗
33. Turco, M. Y. et al. Long-term, hormone-responsive organoid cultures of human endometrium in a chemically defined medium. Nat. Cell Biol. 19, 568–577 (2017).10.1038/ncb3516 ↗
34. Boretto, M. et al. Development of organoids from mouse and human endometrium showing endometrial epithelium physiology and long-term expandability. Development 144, 1775–1786 (2017).10.1242/dev.148478 ↗
35. Kessler, M. et al. The Notch and Wnt pathways regulate stemness and differentiation in human fallopian tube organoids. Nat. Commun. 6, 8989 (2015).
36. Kopper, O. et al. An organoid platform for ovarian cancer captures intra- and interpatient heterogeneity. Nat. Med. 25, 838–849 (2019).10.1038/s41591-019-0422-6 ↗
37. Powell, R. H. & Behnke, M. S. WRN conditioned media is sufficient for in vitro propagation of intestinal organoids from large farm and small companion animals. Biol. Open 6, 698–705 (2017).
38. Derricott, H. et al. Developing a 3D intestinal epithelium model for livestock species. Cell Tissue Res. 375, 409–424 (2019).10.1007/s00441-018-2924-9 ↗
39. Martorelli Di Genova, B., Wilson, S. K., Dubey, J. P. & Knoll, L. J. Intestinal delta-6-desaturase activity determines host range for Toxoplasma sexual reproduction. PLoS Biol. 17, e3000364 (2019).10.1371/journal.pbio.3000364 ↗
40. Post, Y. et al. Snake venom gland organoids. Cell 180, 233–247 (2020).10.1016/j.cell.2019.11.038 ↗
41. Gao, D. et al. Organoid cultures derived from patients with advanced prostate cancer. Cell 159, 176–187 (2014).10.1016/j.cell.2014.08.016 ↗
42. Hoffmeyer, K. et al. Wnt/beta-catenin signaling regulates telomerase in stem cells and cancer cells. Science 336, 1549–1554 (2012).10.1126/science.1218370 ↗
43. Yang, T. B. et al. Mutual reinforcement between telomere capping and canonical Wnt signalling in the intestinal stem cell niche. Nat. Commun. 8, 14766 (2017).
44. Schepers, A. G., Vries, R., van den Born, M., van de Wetering, M. & Clevers, H. Lgr5 intestinal stem cells have high telomerase activity and randomly segregate their chromosomes. EMBO J. 30, 1104–1109 (2011).10.1038/emboj.2011.26 ↗
45. Kodack, D. P. et al. Primary patient-derived cancer cells and their potential for personalized cancer patient care. Cell Rep. 21, 3298–3309 (2017).10.1016/j.celrep.2017.11.051 ↗
46. Masters, J. R. Human cancer cell lines: fact and fantasy. Nat. Rev. Mol. Cell Biol. 1, 233–236 (2000).10.1038/35043102 ↗
47. Yu, K. et al. Comprehensive transcriptomic analysis of cell lines as models of primary tumors across 22 tumor types. Nat. Commun. 10, 3574 (2019).
48. Li, X. et al. Organoid cultures recapitulate esophageal adenocarcinoma heterogeneity providing a model for clonality studies and precision therapeutics. Nat. Commun. 9, 2983 (2018).
49. Kijima, T. et al. Three-dimensional organoids reveal therapy resistance of esophageal and oropharyngeal squamous cell carcinoma cells. Cell. Mol. Gastroenterol. Hepatol. 7, 73–91 (2019).10.1016/j.jcmgh.2018.09.003 ↗
50. Nanki, K. et al. Divergent routes toward Wnt and R-spondin niche independency during human gastric carcinogenesis. Cell 174, 856–869 (2018).10.1016/j.cell.2018.07.027 ↗
51. Seidlitz, T. et al. Human gastric cancer modelling using organoids. Gut 68, 207–217 (2019).10.1136/gutjnl-2017-314549 ↗
52. Yan, H. H. N. et al. A comprehensive human gastric cancer organoid biobank captures tumor subtype heterogeneity and enables therapeutic screening. Cell Stem Cell 23, 882–897 (2018).10.1016/j.stem.2018.09.016 ↗
53. van de Wetering, M. et al. Prospective derivation of a living organoid biobank of colorectal cancer patients. Cell 161, 933–945 (2015).10.1016/j.cell.2015.03.053 ↗
54. Fujii, M. et al. A colorectal tumor organoid library demonstrates progressive loss of niche factor requirements during tumorigenesis. Cell Stem Cell 18, 827–838 (2016).10.1016/j.stem.2016.04.003 ↗
55. Schutte, M. et al. Molecular dissection of colorectal cancer in pre-clinical models identifies biomarkers predicting sensitivity to EGFR inhibitors. Nat. Commun. 8, 14262 (2017).10.1038/ncomms14262 ↗
56. Neal, J. T. et al. Organoid modeling of the tumor immune microenvironment. Cell 175, 1972–1988 (2018).10.1016/j.cell.2018.11.021 ↗
57. Weeber, F. et al. Preserved genetic diversity in organoids cultured from biopsies of human colorectal cancer metastases. Proc. Natl Acad. Sci. USA 112, 13308–13311 (2015).10.1073/pnas.1516689112 ↗
58. Ganesh, K. et al. A rectal cancer organoid platform to study individual responses to chemoradiation. Nat. Med. 25, 1607–1614 (2019).10.1038/s41591-019-0584-2 ↗
59. Yao, Y. et al. Patient-derived organoids predict chemoradiation responses of locally advanced rectal cancer. Cell Stem Cell 26, 17–26 (2019).10.1016/j.stem.2019.10.010 ↗
60. Broutier, L. et al. Human primary liver cancer-derived organoid cultures for disease modeling and drug screening. Nat. Med. 23, 1424–1435 (2017).10.1038/nm.4438 ↗
61. Li, L. et al. Human primary liver cancer organoids reveal intratumor and interpatient drug response heterogeneity. JCI Insight 4, e121490 (2019).10.1172/jci.insight.121490 ↗
62. Nuciforo, S. et al. Organoid models of human liver cancers derived from tumor needle biopsies. Cell Rep. 24, 1363–1376 (2018).10.1016/j.celrep.2018.07.001 ↗
63. Saito, Y. et al. Establishment of patient-derived organoids and drug screening for biliary tract carcinoma. Cell Rep. 27, 1265–1276 (2019).10.1016/j.celrep.2019.03.088 ↗
64. Huang, L. et al. Ductal pancreatic cancer modeling and drug screening using human pluripotent stem cell- and patient-derived tumor organoids. Nat. Med. 21, 1364–1371 (2015).10.1038/nm.3973 ↗
65. Tiriac, H. et al. Organoid profiling identifies common responders to chemotherapy in pancreatic cancer. Cancer Discov. 8, 1112–1129 (2018).10.1158/2159-8290.CD-18-0349 ↗
66. Boretto, M. et al. Patient-derived organoids from endometrial disease capture clinical heterogeneity and are amenable to drug screening. Nat. Cell Biol. 21, 1041–1051 (2019).10.1038/s41556-019-0360-z ↗
67. Hill, S. J. et al. Prediction of DNA repair inhibitor response in short-term patient-derived ovarian cancer organoids. Cancer Discov. 8, 1404–1421 (2018).10.1158/2159-8290.CD-18-0474 ↗
68. Lee, S. H. et al. Tumor evolution and drug response in patient-derived organoid models of bladder cancer. Cell 173, 515–528 (2018).10.1016/j.cell.2018.03.017 ↗
69. Calandrini, C. et al. An organoid biobank for childhood kidney cancers that captures disease and tissue heterogeneity. Nat. Commun. 11, 1310 (2020).10.1038/s41467-020-15155-6 ↗
70. Puca, L. et al. Patient derived organoids to model rare prostate cancer phenotypes. Nat. Commun. 9, 2404 (2018).10.1038/s41467-018-04495-z ↗
71. Tsai, S. et al. Development of primary human pancreatic cancer organoids, matched stromal and immune cells and 3D tumor microenvironment models. BMC Cancer 18, 335 (2018).10.1186/s12885-018-4238-4 ↗
72. Roerink, S. F. et al. Intra-tumour diversification in colorectal cancer at the single-cell level. Nature 556, 457–462 (2018).10.1038/s41586-018-0024-3 ↗
73. Bolhaqueiro, A. C. F. et al. Ongoing chromosomal instability and karyotype evolution in human colorectal cancer organoids. Nat. Genet. 51, 824–834 (2019).10.1038/s41588-019-0399-6 ↗
74. Drost, J. et al. Sequential cancer mutations in cultured human intestinal stem cells. Nature 521, 43–47 (2015).10.1038/nature14415 ↗
75. Drost, J. et al. Use of CRISPR-modified human stem cell organoids to study the origin of mutational signatures in cancer. Science 358, 234–238 (2017).10.1126/science.aao3130 ↗
76. Dekkers, J. F. et al. A functional CFTR assay using primary cystic fibrosis intestinal organoids. Nat. Med. 19, 939–945 (2013).10.1038/nm.3201 ↗
77. Wiegerinck, C. L. et al. Loss of syntaxin 3 causes variant microvillus inclusion disease. Gastroenterology 147, 65–68 (2014).10.1053/j.gastro.2014.04.002 ↗
78. Bigorgne, A. E. et al. TTC7A mutations disrupt intestinal epithelial apicobasal polarity. J. Clin. Invest. 124, 328–337 (2014).10.1172/JCI71471 ↗
79. van Rijn, J. M. et al. Intestinal failure and aberrant lipid metabolism in patients with DGAT1 deficiency. Gastroenterology 155, 130–143 (2018).10.1053/j.gastro.2018.03.040 ↗
80. Dotti, I. et al. Alterations in the epithelial stem cell compartment could contribute to permanent changes in the mucosa of patients with ulcerative colitis. Gut 66, 2069–2079 (2017).10.1136/gutjnl-2016-312609 ↗
81. Howell, K. J. et al. DNA methylation and transcription patterns in intestinal epithelial cells from pediatric patients with inflammatory bowel diseases differentiate disease subtypes and associate with outcome. Gastroenterology 154, 585–598 (2018).10.1053/j.gastro.2017.10.007 ↗
82. Freire, R. et al. Human gut derived-organoids provide model to study gluten response and effects of microbiota-derived molecules in celiac disease. Sci. Rep. 9, 7029 (2019).
83. Soroka, C. J. et al. Bile-derived organoids from patients with primary sclerosing cholangitis recapitulate their inflammatory immune profile. Hepatology 70, 871–882 (2019).10.1002/hep.30470 ↗
84. Nakamoto, N. et al. Gut pathobionts underlie intestinal barrier dysfunction and liver T helper 17 cell immune response in primary sclerosing cholangitis. Nat. Microbiol. 4, 492–503 (2019).10.1038/s41564-018-0333-1 ↗
85. Fujii, M., Clevers, H. & Sato, T. Modeling human digestive diseases with CRISPR–Cas9-modified organoids. Gastroenterology 156, 562–576 (2019).10.1053/j.gastro.2018.11.048 ↗
86. Schwank, G. et al. Functional repair of CFTR by CRISPR/Cas9 in intestinal stem cell organoids of cystic fibrosis patients. Cell Stem Cell 13, 653–658 (2013).10.1016/j.stem.2013.11.002 ↗
87. Matano, M. et al. Modeling colorectal cancer using CRISPR–Cas9-mediated engineering of human intestinal organoids. Nat. Med. 21, 256–262 (2015).10.1038/nm.3802 ↗
88. Jager, M. et al. Deficiency of nucleotide excision repair is associated with mutational signature observed in cancer. Genome Res. 29, 1067–1077 (2019).10.1101/gr.246223.118 ↗
89. Fessler, E. et al. TGFbeta signaling directs serrated adenomas to the mesenchymal colorectal cancer subtype. EMBO Mol. Med. 8, 745–760 (2016).10.15252/emmm.201606184 ↗
90. Artegiani, B. et al. Probing the tumor suppressor function of BAP1 in CRISPR-engineered human liver organoids. Cell Stem Cell 24, 927–943 (2019).10.1016/j.stem.2019.04.017 ↗
91. Kawasaki, K. et al. Chromosome engineering of human colon-derived organoids to develop a model of traditional serrated adenoma. Gastroenterology 158, 638–651 (2020).10.1053/j.gastro.2019.10.009 ↗
92. Matsuzawa-Ishimoto, Y. et al. Autophagy protein ATG16L1 prevents necroptosis in the intestinal epithelium. J. Exp. Med. 214, 3687–3705 (2017).10.1084/jem.20170558 ↗
93. Pott, J., Kabat, A. M. & Maloy, K. J. Intestinal epithelial cell autophagy is required to protect against TNF-induced apoptosis during chronic colitis in mice. Cell Host Microbe 23, 191–202 (2018).10.1016/j.chom.2017.12.017 ↗
94. Lindemans, C. A. et al. Interleukin-22 promotes intestinal-stem-cell-mediated epithelial regeneration. Nature 528, 560–564 (2015).10.1038/nature16460 ↗
95. Gronke, K. et al. Interleukin-22 protects intestinal stem cells against genotoxic stress. Nature 566, 249–253 (2019).10.1038/s41586-019-0899-7 ↗
96. Nanki, K. et al. Somatic inflammatory gene mutations in human ulcerative colitis epithelium. Nature 577, 254–259 (2020).10.1038/s41586-019-1844-5 ↗
97. Yui, S. et al. YAP/TAZ-dependent reprogramming of colonic epithelium links ECM remodeling to tissue regeneration. Cell Stem Cell 22, 35–49 (2018).10.1016/j.stem.2017.11.001 ↗
98. Nusse, Y. M. et al. Parasitic helminths induce fetal-like reversion in the intestinal stem cell niche. Nature 559, 109–113 (2018).10.1038/s41586-018-0257-1 ↗
99. Sato, T. & Clevers, H. Growing self-organizing mini-guts from a single intestinal stem cell: mechanism and applications. Science 340, 1190–1194 (2013).10.1126/science.1234852 ↗
100. Tao, Y. et al. Aging-like spontaneous epigenetic silencing facilitates Wnt activation, stemness, and BrafV600E-induced tumorigenesis. Cancer Cell 35, 315–328 (2019).10.1016/j.ccell.2019.01.005 ↗